Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study

BackgroundA chemotherapy of rituximab, fludarabine and cyclophosphamide (R-FC) has been accepted as a promising frontline chemotherapy in selected patients with chronic lymphocytic leukemia (CLL). Although R-FC regimen is a relatively dose-dense regimen and neutropenia incidence is more than 50%, pr...

Full description

Bibliographic Details
Published in:Frontiers in Oncology
Main Authors: Youngwoo Jeon, Duk-Hwan Yang, Suk-Joong Oh, Jin-Hee Park, Jung-Ah Kim, Sung-Young Kim, Chul-Won Choi, Won-Sik Lee, In-Ho Kim, Yeung-Chul Mun, Gi June Min, Ki-Seong Eom, Seok-Goo Cho
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.998014/full